Modafinil augmentation of phenelzine for residual fatigue in dysthymia.
Ashton
Adam Keller
AK
D001559:Benzhydryl Compounds / Q000627:therapeutic use*; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D015897:Comorbidity; D006970:Disorders of Excessive Somnolence / Q000188:drug therapy / Q000453:epidemiology; D004359:Drug Therapy, Combination; D019263:Dysthymic Disorder / Q000188:drug therapy* / Q000453:epidemiology / Q000523:psychology; D005221:Fatigue / Q000188:drug therapy* / Q000453:epidemiology; D005260:Female; D006801:Humans; D008875:Middle Aged; D000077408:Modafinil; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use*; D010624:Phenelzine / Q000627:therapeutic use*; D016896:Treatment Outcome
D001559:Benzhydryl Compounds; D000697:Central Nervous System Stimulants; D008996:Monoamine Oxidase Inhibitors; D010624:Phenelzine; D000077408:Modafinil